Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Questcor Provides Updated New Paid Prescription Trends

September 10, 2011 By Bio-Medicine.Org

ANAHEIM, Calif., Sept. 10, 2011 /PRNewswire/ — Commencing on
September 12, 2011, Questcor Pharmaceuticals, Inc. (NASDAQ:
QCOR
) will utilize an updated presentation for meetings with
investors. This presentation was filed under Form 8-K with the SEC
on Friday, September 9 at 3 p.m. PST and will be posted on the
SEC’s website prior to market open on Monday, September 12.
 The presentation includes an update regarding prescription
trends for the Company’s primary product, H.P. Acthar Gel
(repository corticotropin injection) through the end of August 2011
as follows:

– For acute exacerbations of multiple sclerosis (MS), the
run-rate of new, paid prescriptions for the quarter ending
September 30, 2011, based on the first two months of the quarter,
is approximately 10% higher than the number of new, paid
prescriptions in the quarter ended June 30, 2011.

– For each of nephrotic syndrome (NS) and infantile spasms (IS),
the run-rate of new, paid prescriptions for the quarter ending
September 30, 2011, based on the first two months for the quarter
is approximately equal to the number of new, paid prescriptions in
the quarter ended June 30, 2011.

The Company has calculated “run-rate” for the quarter ending
September 30, 2011 by taking its preliminary results for the first
two months of the quarter and multiplying that amount by 1.5.

The Company is also disclosing the following unaudited balance
sheet information as of September 6, 2011:

– Cash, cash equivalents and short-term investments: $170
million.

– Accounts receivable: $19 million.

Questcor expects to post the updated presentation on its website
prior to Monday, September 12.

Important Information Regarding Prescriptions and Net
Sales

Net sales of Acthar are derived from our sales of vials to
CuraScript SD, which in turn sells Acthar primarily to specialty
pharm

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech